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Bio-Medical
Hydrocyclone/Filter for Concentrating Biomarkers From Soil
This apparatus could detect biomarkers or chemical waste in soil. 
NASA’s Jet Propulsion Laboratory, Pasadena, California
The hydrocyclone-filtration extractor
(HFE), now undergoing development, is
a simple, robust apparatus for process-
ing large amounts of soil to extract trace
amounts of microorganisms, soluble or-
ganic compounds, and other biomark-
ers from soil and to concentrate the ex-
tracts in amounts sufficient to enable
such traditional assays as cell culturing,
deoxyribonucleic acid (DNA) analysis,
and isotope analysis. Originally intended
for incorporation into a suite of instru-
ments for detecting signs of life on Mars,
the HFE could also be used on Earth for
similar purposes, including detecting
trace amounts of biomarkers or chemi-
cal wastes in soils.
In addition to a conical separator ves-
sel typical of a hydrocyclone, the HFE in-
cludes a pump, a sample container, an
electropositive nanoparticle filter, and
associated plumbing (see figure). The
hydrocyclone serves to separate both cel-
lular-sized particles (<5 µm) and dis-
solved organic compounds from the
bulk soil (consisting mostly of particles
larger than 5 µm). The electropositive
filter serves to capture cellular biomass
and remove particles from the extract
with maximal capacity (that is, minimal
clogging).
The soil sample is prepared by mix-
ing it with sterile water or another suit-
able solvent to form a slurry, which is
pumped to the hydrocyclone separator
vessel in tangential streams at the top
(wide) end to form two concentric op-
posing vortices at high hydrodynamic
pressures to effect separation based on
particle size. The spinning motion of
the injected slurry is accelerated by the
conical taper, creating a large centrifu-
gal force that causes the larger parti-
cles to rapidly separate from the rest of
the flow and leave the vessel as part of
underflow through the bottom (nar-
row) end of the separator vessel. The
liquid containing suspended particles
smaller than 5 µm leaves the vessel as
the overflow (which is larger than the
underflow) at the top (wide) end of
the vessel. The overflow is then fed
through the filter.
The filter contains electropositive alu-
minum nanotubes embedded in a glass-
fiber matrix. The filter has a nominal
pore size of 2 µm, but can collect biolog-
ical particles having sizes down to frac-
tions of a micron, on the basis of electro-
static charge, without clogging. The
combination of the hydrocyclone and
the electropositive nanoparticle filter is
capable of extracting 99 percent of parti-
cles smaller than 5 µm from the soil sam-
ple and retaining them for analysis. In
the prototype HFE depicted schemati-
cally in the filter, the underflow and the
effluent from the filter are fed back to
the sample container. It is envisioned
that the fully developed HFE could oper-
ate in a continuous-flow mode, making it
possible to extract biomarkers from a
large volume (e.g., 1 m3) of soil using a
minimal amount (e.g., 1 L) of solvent.
In a field test, the prototype HFE was
made to process a slurry consisting of 4
L of sterile water mixed with 4 L of Ata-
cama-desert soil, which contains such
low concentrations of recoverable mi-
croorganisms as to be nearly impossible
to analyze in the absence of an extrac-
tion-and-concentration process. After 15
minutes of recycling the slurry in the
HFE, the maximum loading of the filter
was reached. The filter was removed and
dried and found to contain 100 g of fine
particulate material, which, in turn, was
removed from the filter in a laboratory
for further analysis. Whereas traditional
extraction protocols yielded no micro-
bial colony-forming units, the extract
from the HFE filter yielded microbes too
numerous to count on standard growth
plates. On the basis of development
plans and this result, it is expected that
In this Prototype HFE, a soil/water slurry is pumped from a sample container through a hydrocyclone
separator vessel and a filter and is recycled through the sample container. The hydrocyclone separates
most of the soil particles into an underflow. The filter traps smaller particles in the overflow.
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Activating STAT3 Alpha for Promoting Healing of Neurons 
Natural anti-apoptotic, pro-axogenic mechanisms are stimulated artificially.
Ames Research Center, Moffett Field, California
A method of promoting healing of in-
jured or diseased neurons involves phar-
macological activation of the STAT3
alpha protein. Usually, injured or dis-
eased neurons heal incompletely or not
at all for two reasons: (1) they are sus-
ceptible to apoptosis (cell death); and
(2) they fail to engage in axogenesis —
that is, they fail to re-extend their axons
to their original targets (e.g., muscles or
other neurons) because of insufficiency
of compounds, denoted neurotrophic
factors, needed to stimulate such exten-
sion. The present method (see figure) of
treatment takes advantage of prior re-
search findings to the effect that the
STAT3 alpha protein has anti-apoptotic
and pro-axogenic properties.
As used here, “STAT” signifies “signal
transducer and activator of transcrip-
tion.” “STAT3 alpha” is the name of one
of a number of transcription factors and
of the gene responsible for producing it.
Transcription factors activate the expres-
sion of other genes and otherwise gener-
ally regulate gene expression. The
STAT3 alpha protein is activated in re-
sponse to such extracellular factors as
hormones and growth factors as well as
the aforementioned neurotrophic fac-
tors. The STAT3 alpha protein associates
with trans-membrane receptors for these
extracellular factors. When activated by
growth factors and hormones, STAT3
alpha prevents apoptosis.
Recent findings from the Life Sci-
ences and Microgravity Division of Ames
Research Center now show that when ac-
tivated by neurotrophic factors STAT3
alpha, in addition to preventing apopto-
sis, also promotes innervation. The natu-
ral activation of the STAT3 alpha protein
is effected by phosphorylation of a spe-
cific tyrosine amino acid. Upon such
phosphorylation, two STAT3 alpha mol-
ecules can form a homo-dimer. The tyro-
sine on a given STAT3 protein molecule
that becomes phosphorylated resides on
a flexible activation loop sequence that
binds to a pocket, denoted the SH2 do-
main, of another STAT3 protein mole-
cule. Upon homo-dimerization, STAT3
alpha is retained in the nucleus of cells,
where it binds specific deoxyribonucleic
acid (DNA) sequences and activates the
expression of nearby genes. Thus,
homo-dimerized STAT3 alpha protein is
part of a signal-transduction complex
that relays chemical signals from hor-
mones, growth factors, and neu-
rotrophic factors outside the cell directly
to the DNA inside the cell. In so doing,
it activates genes that exert anti-apop-
totic and axogenic effects.
Hence, the present method is based on
the design of a new class of pharmacolog-
ical agents (homo and heteroditopic
Janus molecules) to promote artificial
dimerization and pharmacological activa-
tion of therapeutic targets, in this case
the STAT3 alpha protein. The precise lo-
cation of each atom in the STAT3 homo-
dimer is known and it is possible to use
this structural information along with
molecular modeling and docking pro-
grams to rationally design a Janus mole-
cule having the correct sizes and shape,
and/or to bind to STAT3 alpha preferen-
tially to other proteins that are similar to
STAT3 alpha. The compound can be syn-
thesized by techniques that are well estab-
lished in the pharmaceutical industry
and can be formulated to be adminis-
tered alone or in combination with other
therapeutic compounds. 
This work was done by Greg Conway of
Ames Research Center.
This invention is owned by NASA, and a
patent application has been filed. Inquiries
concerning rights for the commercial use of
this invention should be addressed to the
Ames Technology Partnerships Division at
(650) 604-2954. Refer to ARC-15475-1.
Motor Neurons visualized by a dark staining reaction are seen exiting the spinal cord, from the right
side of each panel, innervating adjacent muscle tissue.
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cellular-extract concentrations obtained
by use of the fully developed HFE will be
at least 103 times those obtained by
means of state-of-the art extraction
methods heretofore used in environ-
mental microbiology.
This work was done by Adrian Ponce of
Caltech and Donald Obenhuber of National
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Laboratory. Further information is contained
in a TSP (see page 1).
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